Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.48 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.48 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.48 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10967692 | 0.94 | ALDH1A1 (0.63) | ALDH1A1S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL10098458 | 0.91 | ALDH1A1 (0.50) | ALDH1A1S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL16103645 | 0.91 | ALDH1A1 (0.50) | ALDH1A1S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL292614 | 0.85 | ALDH1A1 (0.81) | ALDH1A1MEN1KMT2AENPEPFFAR4 | |
| SCHEMBL5334204 | 0.84 | ALDH1A1 (0.62) | ALDH1A1S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL7131352 | 0.84 | ALDH1A1 (0.52) | ALDH1A1S1PR2S1PR1S1PR3S1PR4 | |
| SCHEMBL2937973 | 0.83 | ALDH1A1 (0.85) | ALDH1A1MEN1KMT2AENPEPFFAR4 | |
| SCHEMBL1879842 | 0.83 | ALDH1A1 (0.85) | ALDH1A1MEN1KMT2AENPEPFFAR4 | |
| SCHEMBL1878455 | 0.83 | ALDH1A1 (0.85) | ALDH1A1MEN1KMT2AENPEPFFAR4 | |
| SCHEMBL1875991 | 0.83 | ALDH1A1 (0.85) | ALDH1A1MEN1KMT2AENPEPFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0271817-B1 | PROCESS FOR PREPARING CAPROLACTAM FROM 6-AMINOCAPROIC ACID OR FROM ITS ESTERS AND/OR AMIDES | BASF Aktiengesellschaft (DE) | 1992-11-25 | — | — | EP | claimed |
| US-12421279-B2 | Cyclic peptide antiviral agents and methods using same | DREXEL UNIVERSITY (US) | 2025-09-23 | — | — | US | disclosed |
| US-20250099533-A1 | ADIPONECTIN PEPTIDOMIMETICS FORMULATIONS | ALLYSTA PHARMACEUTICALS INC (US) | 2025-03-27 | — | — | US | disclosed |
| US-20250059235-A1 | CYCLIC PEPTIDE ANTIVIRAL AGENTS AND METHODS USING SAME | UNIV DREXEL (US) | 2025-02-20 | — | — | US | disclosed |
| US-12201668-B2 | Adiponectin peptidomimetics formulations | ALLYSTA PHARMACEUTICALS, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| US-20230355708-A1 | COMPOSITIONS FOR INHIBITING VIRAL ENTRY AND METHODS USING SAME | UNIV DREXEL (US) | 2023-11-09 | — | — | US | disclosed |
| CN-115919996-A | Adiponectin peptidomimetics for the treatment of ophthalmic diseases | 雅利斯塔制药公司 | 2023-04-07 | — | — | CN | disclosed |
| US-20230074446-A1 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | ALLYSTA PHARMACEUTICALS INC (US) | 2023-03-09 | — | — | US | disclosed |
| US-20220331393-A1 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | ALLYSTA PHARMACEUTICALS INC (US) | 2022-10-20 | — | — | US | disclosed |
| US-11464825-B2 | Adiponectin peptidomimetics for treating ocular disorders | ALLYSTA PHARMACEUTICALS, INC. (US) | 2022-10-11 | — | — | US | disclosed |
| WO-2012048033-A2 | NOVEL COMPOSITIONS FOR INHIBITING VIRUS ENTRY AND PROMOTING VIROLYISIS, AND METHODS THEREOF | DREXEL UNIVERSITY (US) | 2012-04-12 | — | — | WO | disclosed |
| WO-2011002673-A1 | LEPTIN AGONIST AND METHODS OF USE | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2011-01-06 | — | — | WO | disclosed |
| US-7820757-B2 | Production of a titania-pigmented polyamide | BASF SE (DE) | 2010-10-26 | — | — | US | disclosed |
| WO-2010117785-A1 | LEPTIN ANTAGONIST AND METHODS OF USE | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2010-10-14 | — | — | WO | disclosed |
| US-7285601-B2 | Fibers, films, and moldings; monoolefinically unsaturated monocarboxylic acid of the formula CH2 .dbd. CH (CH2)3 COOH chemically bonded at the end of the polymer chain via an amide group | BASF AKTIENGESELLSCHAFT (DE) | 2007-10-23 | — | — | US | disclosed |
| US-20060063907-A1 | Polyamides | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-23 | — | — | US | disclosed |
| US-20060047057-A1 | Method for the production of a polyamide pigmented with titanium dioxide | BASF SE (DE) | 2006-03-02 | — | — | US | disclosed |
| US-20050159579-A1 | Inherently crosslinkable polyamides | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-21 | — | — | US | disclosed |
| US-20040176523-A1 | to produce fibers, sheet materials and moldings having improved heat stabilization | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-09 | — | — | US | disclosed |
| US-20040147645-A1 | System made from a polyamide and a 2,6-diaminopyridine derivative and method for producing of said system | BASF AKTIENGESELLSCHAFT (DE) | 2004-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059235-A1 | CYCLIC PEPTIDE ANTIVIRAL AGENTS AND METHODS USING SAME | ZC3HAV1, VIP, LNPEP | ALDH1A1 4630/4885S1PR2 2923/4885S1PR1 2353/4885 |
| US-12421279-B2 | Cyclic peptide antiviral agents and methods using same | ZC3HAV1, VIP, LNPEP | ALDH1A1 4630/4885S1PR2 2923/4885S1PR1 2353/4885 |
| US-20230355708-A1 | COMPOSITIONS FOR INHIBITING VIRAL ENTRY AND METHODS USING SAME | GALNT1, GALNT2, LGALS1 | ALDH1A1 2584/4885S1PR2 4030/4885S1PR1 3369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.